Identifier | Name |
---|---|
1299311 | Potassium channel silencing by constitutive endocytosis and intracellular sequestration |
1296210 | Potassium channels: newly found players in synaptic plasticity |
180308 | Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites |
9674255 | Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib) |
9833838 | Potential role for snoRNAs in PKR activation during metabolic stress |
1458568 | Potential role of Rab4 in the regulation of subcellular localization of Glut4 in adipocytes |
1454667 | Potential role of TBC1D4 in enhanced post-exercise insulin action in human skeletal muscle |
2460103 | Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis |
9694202 | Potential roles of PP2A-Rac1 signaling axis in pancreatic β-cell dysfunction under metabolic stress: Progress and Promise |
2130364 | Potential sites for processing of the human invariant chain by cathepsins D and E |
5096504 | Potential targets for HSF1 within the preinitiation complex |
8984151 | Potentiation of RNA polymerase II transcription by Gal4-VP16 during but not after DNA replication and chromatin assembly |
9697462 | Practitioner review: early adversity and developmental disorders |
9696382 | Pragmin, a novel effector of Rnd2 GTPase, stimulates RhoA activity |
9709154 | Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma |
9733278 | Pramlintide in the treatment of diabetes mellitus |
9617396 | Prazosin in the treatment of hypertension |
5634801 | Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity |
913222 | Prdm9 controls activation of mammalian recombination hotspots |
1368954 | Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis |
9021429 | Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression |
9015723 | Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma |
9750110 | Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine |
72166 | Pre-mRNA splicing: the discovery of a new spliceosome doubles the challenge. |
1266696 | Pre-pro-B cell growth-stimulating factor (PPBSF) upregulates IL-7Ralpha chain expression and enables pro-B cells to respond to monomeric IL-7 |
5637613 | Pre-steady-state fluorescence analysis of damaged DNA transfer from human DNA glycosylases to AP endonuclease APE1 |
873818 | Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains |
8855957 | Precipitin reaction between Sda-active human Tamm-Horsfall glycoprotein and anti-Sda-serum |
83611 | Precise binding of single-stranded DNA termini by human RAD52 protein. |
163295 | Precise identification of individual promoters for transcription of each strand of human mitochondrial DNA |
2453754 | Precise mapping of an IGF-I-binding site on the IGF-1R |
3247704 | Precise regulation of porcupine activity is required for physiological Wnt signaling |
9629074 | Precise timing of ATPase activation drives targeting of tail-anchored proteins |
9756000 | Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression |
9681746 | Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases |
9674258 | Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment |
9755171 | Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models |
9754230 | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine |
9678571 | Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms |
9755986 | Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors |
2077415 | Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma |
9699354 | Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor |
8865218 | Precursor convertases in the secretory pathway, cytosol and extracellular milieu |
9833736 | Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity |
1254367 | Precursor oxidation by Mia40 and Erv1 promotes vectorial transport of proteins into the mitochondrial intermembrane space |
75337 | Precursor structure, expression, and tissue distribution of human guanylin. |
2318448 | Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features |
9793513 | Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system |
9631243 | Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A |
9624765 | Predicting the targeting of tail-anchored proteins to subcellular compartments in mammalian cells |
353639 | Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris |
9699355 | Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia |
8850684 | Prediction of structural domains of TAP reveals details of its interaction with p15 and nucleoporins |
1168411 | Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7 |
1112529 | Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation |
© 2024 Reactome